1. Breast cancer-specific survival (BCSS) in patients (pts) with nodenegative (N0) and node-positive (N+) breast cancer (BC) guided by the 21-gene assay: a SEER-genomic real-world evidence study. (March 2019) Authors: Winer, E.P.; Shak, S.; Sledge, G.W.; Albain, K.S.; Mamounas, E.P.; Jakubowski, D.M.; Petkov, V.I.; Wolmark, N.; Hortobagyi, G.N. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer after prior adjuvant therapy with an aromatase inhibitor (AI): NRG Oncology/NSABP B-42. (March 2017) Authors: Mamounas, E.; Bandos, H.; Lembersky, B.; Geyer, C.; Geyer, C.; Fehrenbacher, L.; Graham, M.; Paik, S.; Swain, S.; Wickerham, L.; Wolmark, N. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of disease-free survival (DFS) as a surrogate for overall survival (OS) in the adjuvant therapy of HER2-positive early breast cancer (EBC) calls for individual-patient data (IPD). (March 2017) Authors: Saad, E.; Delaloge, S.; Mavroudis, D.; Perez, E.; Piccart-Gebhart, M.; Schneider, B.; Wolmark, N.; Buyse, M.; Burzykowski, T. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer. Issue 2 (February 2019) Authors: Golshan, M.; Wong, S.; Loibl, S.; Huober, J.B.; O'Shaughnessy, J.; Rugo, H.S.; Wolmark, N.; McKee, M.D.; Maag, D.; Sullivan, D.M.; Metzger-Filho, O.; Von Minckwitz, G.; Geyer, C.E.; Sikov, W.M.; Untch, M. Journal: European journal of surgical oncology Issue: Volume 45:Issue 2(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P264 Predicting late distant recurrence risk in ER+ breast cancer after five years of tamoxifen. (March 2015) Authors: Mamounas, E.; Wolmark, N.; Baehner, F.L.; Butler, S.M.; Tang, G.; Jamshidian, F.; Sing, A.P.; Shak, S.; Paik, S. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗